13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001591986-25-000004
Total Value
$55.8M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMGEN INC | AMGN | 60,000 | $18.7M | 33.51% |
| 2 | BLUEPRINT MEDICINES CORP | 09627Y109 | 83,926 | $7.4M | 13.32% |
| 3 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 550,130 | $7.0M | 12.57% |
| 4 | PROTAGONIST THERAPEUTICS INC | PTGX | 81,692 | $4.0M | 7.08% |
| 5 | KYMERA THERAPEUTICS INC | KYMR | 138,521 | $3.8M | 6.80% |
| 6 | PRECISION BIOSCIENCES INC | DTIL | 726,149 | $3.5M | 6.21% |
| 7 | ARVINAS INC | ARVN | 360,766 | $2.5M | 4.54% |
| 8 | REGENXBIO INC | RGNX | 271,302 | $1.9M | 3.48% |
| 9 | ADICET BIO INC | ACET | 2,456,194 | $1.9M | 3.32% |
| 10 | BICYCLE THERAPEUTICS PLC | BCYC | 171,695 | $1.5M | 2.61% |
| 11 | IMMATICS N.V | IMTX | 304,902 | $1.4M | 2.47% |
| 12 | REPARE THERAPEUTICS INC | 760273102 | 1,293,715 | $1.3M | 2.29% |
| 13 | ZYMEWORKS INC | ZYME | 84,482 | $1.0M | 1.80% |